There are unique considerations for cancers when they arise in brain tissue, including the challenge of choosing agents that cross the blood brain barrier. When to suspect brain lesions in your patients, understanding the disease process, defining metabolic characteristics that we can exploit and knowing which natural agents may mitigate symptoms and alter the course of the disease.